Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00260598 · ClinicalTrials.gov registry record · Phase 2
LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer
A Phase 2 study, sponsored by University of Pittsburgh.
- Terminated
- Registry status
- Phase 2
- Development phase
- 142
- Enrollment target
NCT00260598 is a Phase 2 study that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 142 participants.
The verdict
NCT00260598, a Phase 2 study, was terminated before completion, sponsored by University of Pittsburgh.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 142 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the usefulness and accuracy of the "LIFE-Lung Bronchoscopy" to identify early changes in lung tissues that show precancerous, cancer in situ (just beginning and not spread) and microscopic invasive cancer lesions versus the ability of the standard "White Light Bronchoscopy" to identify the same. This will be done as a part of routine monitoring bronchoscopy. Patients who have had a surgical resection of non-small cell lung cancer (NSCLC) and with no current evidence of disease (NED) will be eligible. Also eligible are patients who have had head or neck squamous cell carcinoma with radical head and/or neck dissection and who are currently NED. Patients with severe chronic, obstructive, pulmonary disease shown by pulmonary function testing abnormalities will also be eligible. In addition to the specialized bronchoscopy, doctors will be investigating the use of imaging spectroscopy. This is using an optical (visualizing) procedure to measure the light reflected back from tissue. Different lesions and normal tissues reflect light differently and in specific color wavelengths. By using measurements over time (different examinations/bronchoscopies) very small changes can be seen. This may allow eventually for very early diagnosing of precancerous or cancer in situ lesions, allowing for earlier treatment.
Interventions
- PROCEDURE LIFE Bronchoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 1998-08 |
| Est. Completion | 2017-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00260598
The ClinicalTrials.gov registry entry for NCT00260598 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LIFE Bronchoscopy is the first listed.
NCT00260598 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00260598 about?
NCT00260598 is a clinical study titled "LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer". The purpose of the study is to evaluate the usefulness and accuracy of the "LIFE-Lung Bronchoscopy" to identify early changes in lung tissues that show precancerous, cancer in situ (just beginning and not spread) and microscopic invasive cancer lesions versus the ability of the standard "White Light...
What is the current status of trial NCT00260598?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 142 participants. The study started on 1998-08. Estimated completion is 2017-03.
What interventions are being tested in trial NCT00260598?
The interventions under investigation include: LIFE Bronchoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT00260598?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.